
SmoltVision is an innovative real-time RT‑PCR analysis that determines when smolt are ready to be transferred to seawater. We measure three genes expressed in the gills and combine this with production data and insights from more than 150,000 completed smolt analyses. Farmers receive comprehensive, detailed information on seawater readiness—before the transition occurs.
SmoltVision helps producers decide the optimal time to move smolt to seawater. Timing is critical for survival at sea—if fish are released at the wrong time, mortality can increase.
“In recent years, we’ve seen a growing need for new and more accurate analyses to achieve an objective measurement of seawater tolerance,” says Elise Hjelle, Head of Smolt at Pharmaq Analytiq.
“The need is increasing as hatchery production regimes evolve rapidly,” Hjelle explains. “Smolt production is becoming more intensive, smolt are larger, and the biology is under greater pressure as a result. The use of salt-enriched feed is rising, and production systems are becoming more advanced—both in RAS and land-based facilities.”
SmoltVision measures the expression of three genes that play key roles in salmon gills during smoltification and the development of seawater tolerance:
SmoltVision samples can also be used for pathogen screening, eliminating the need for additional sampling if you want further analyses alongside seawater tolerance monitoring.
The analysis is highly useful when unexpected changes in behavior or appearance are observed in parr and smolt during development. SmoltVision can help identify potential underlying causes and assess whether they may affect the fish’s ability to tolerate transfer to seawater.
Such changes may indicate that smoltification is underway, or that the group is following an atypical smoltification trajectory. Smoltification is a complex process influenced by multiple factors, including light, temperature, and water quality, in addition to fish size.
Large-smolt production has expanded significantly in recent years. In some regions, such as Norway, notable growth has been observed. SmoltVision is valuable in this context.
Larger smolt often adapt to seawater in less predictable ways than traditionally sized smolt—for example, they do not always respond to light cues as expected. In such cases, SmoltVision can provide more detailed insights than other smolt analyses.
SmoltVision was developed by researchers at the University of Bergen in collaboration with Pharmaq Analytiq. Since its launch in 2017, the team has analyzed more than 150,000 fish using the tool.
“Our extensive experience has given us unique expertise in smolt and seawater adaptation. We apply that experience every day when evaluating results from new fish groups,” says Elise Hjelle.
In addition to the analysis results themselves, information about the fish and their environment is included in the assessment to provide a final conclusion. The outcome is a holistic evaluation with tailored recommendations for the fish group.
Customers are encouraged to contact us in an early phase of the planning of a project. Our team can advise on sampling and study design in addition to relevant analyses, to optimize project setup and results.
Customer projects
PHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people. Production facilities, administration and research and development activities are based in Norway with subsidiaries in Chile, United Kingdom, Vietnam, Turkey, Spain, Panama and Hong Kong. PHARMAQ has approximately 300 employees. The company's products are marketed in Europe, North and South America, and Asia. For further information, visit the company's website at www.pharmaq.com. Privacy Policy. Cookie Policy. Terms of Use.
Copyright © 2020 Zoetis LLC. All rights reserved.